Primary information |
---|
PRRID | PRRID_2321 |
Ligand Name | M-Tri-DAP |
Source | Gram-negative and Gram-positive bacteria |
Sequence of ligand | CC(C(=O)NC(CCC(=O)NC(CCCC(C(=O)O)N)C(=O)O)C(=O)O)N |
Length | NA |
Type | Peptidoglycan |
Occurence | Synthetic |
Role of Ligand | Agonist recognition triggers receptor oligomerization and recruitment of signaling molecules that drive NF-κB-mediated expression of inflammatory cytokines |
Name of receptor | Nod-like receptor C2 (NLRC2) |
Type of receptor | NOD-like receptor (NLR) |
Source | Human |
Localization | Intracellular |
Domain | C-terminal leucine-rich regions and NOD domains |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | triggering production of β-defensins via an NF-κB signaling pathway |
Assay used | NA |
PMID | 28776416 |
Year of Publication | 2017 |
Pubchem assay | NA |
Primary information |
---|
PRRID | PRRID_2321 |
Ligand Name | M-Tri-DAP |
Source | Gram-negative and Gram-positive bacteria |
Sequence of ligand | CC(C(=O)NC(CCC(=O)NC(CCCC(C(=O)O)N)C(=O)O)C(=O)O)N |
Length | NA |
Type | Peptidoglycan |
Occurence | Synthetic |
Role of Ligand | Agonist recognition triggers receptor oligomerization and recruitment of signaling molecules that drive NF-κB-mediated expression of inflammatory cytokines |
Name of receptor | Nod-like receptor C2 (NLRC2) |
Type of receptor | NOD-like receptor (NLR) |
Source | Human |
Localization | Intracellular |
Domain | C-terminal leucine-rich regions and NOD domains |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | triggering production of β-defensins via an NF-κB signaling pathway |
Assay used | NA |
PMID | 28776416 |
Year of Publication | 2017 |
Pubchem assay | NA |